mCig® Inc. Announces Upcoming Release of CBD/THC

New Post Public Reply Private Reply Replies (1) Message Board
Health1 MattySimone #1444
mCig® Inc. Announces Upcoming Release of CBD/THC Pre-Loaded Disposable Vape
The EM-J™ Disposable Vape Pen with CBD/THC features Patent-Pending e-liquid

BEVERLY HILLS, Calif., Jan. 14, 2015 (GLOBE NEWSWIRE) -- mCig® Inc.(OTCBB: MCIG) As the market for legal medical and recreational marijuana extracts and as safer, more convenient ways of consuming them converges, mCig today announced that it is rolling out the EM-J™, a new pre-loaded vaporizing pen thru its' Colorado-based subsidiary mCig, CBD Technologies. The unique bundled product combines the highest quality THC and CBD concentrated oils pre-loaded into a convenient, discrete vaporizing pen device, which requires no flame, and produces no smoke or odor.
At the heart of the EM-J™ is a revolutionary new vaporizing liquid that uses a non-toxic thinning fluid. Incorporating a newly developed processing chamber and closed-loop extraction system, the EM-J™ is expected to replace today's conventional pens, which typically use chemicals like Propylene Glycol (PG) or Vegetable Glycerin (VG). Many users have a physical intolerance to chemical-based pens, while others have complained about a chemical-flavored after-taste when inhaling. mCig Inc. engineers have developed a much cleaner approach to vaporization thanks to a patent-pending technique within the extraction process. Versions of the EM-J™ will also be available on an OEM basis for extraction companies, growers, and dispensaries as well.

According to Paul Rosenberg, mCig, Inc. CEO, the market for cannabis extracts is projected at $2 billion annually with expected growth to $10 billion by 2018, and the Company is well suited to become a dominant player in all aspects of the market segment. "More than any other company today, we are vertically integrated and optimized to best serve this quickly growing market. Our new line of EM-J™ vaporizer pens, along with our advanced non-toxic extraction process, extraction machines and facilities, address the most pressing needs of today's medical and recreational marijuana providers. Along with our recent investment in our CannaProTech, LLC subsidiary, operating out of Oregon, we are quickly putting the pieces together to be an industry powerhouse," explained Paul Rosenberg.

Rosenberg also points to the Company's recently launched Colorado-based subsidiary, mCig CBD Technologies, LLC as another key initiative underscoring the company's long-term commitment to extracts. The subsidiary is responsible for designing and manufacturing a new line of products that will leverage its EM-J™ technology for delivery of Cannabis plant derivatives, largely around CBD. CBD, or Cannabidiol, is an active compound in marijuana with and a wide range of potential medical benefits and none of the psychoactive effects of THC. "Our investments in and around THC and CBD extracts and extract delivery systems reflects the overall growing market enthusiasm for extract-based delivery forms. This is an area we intend to lead and innovate through continued research and product development across a wide-range of consumer devices, edibles and extractions, as well as enterprise-grade equipment," added Paul Rosenberg.

mCig, Inc. is currently in the process of repositioning itself from a dynamic vaporizer company with price-disruptive products into an umbrella holding company covering a wide spectrum of profit centers in the growing Cannabis industry. In the last year since the initial sales of the mCig® 2.0 began until now, the company has sold 10's of thousands of mCig® 2.0/2.5 devices at disruptive price points of $10-$19. mCig, Inc. plans on continuing this trend with the recent release of the mCig® 3.0 and Rick Ross Edition BO$S mCig® 3.0.

With the advent of the mCig® 3.0, mCig, Inc. has delivered an innovative device that is both price disruptive and a game changer on quality at only $99 MSRP. In recent weeks, the average sales price per transaction nearly doubled thanks to the mCig® 3.0 and Rick Ross BO$S devices. The company plans on releasing a slimmed down version of the mCig 3.0 in the next 30 days. The new device will be the mCig® 4.0 and it will be slightly wider and longer than the mCig® 2.5 with a price point of $60 or less.

The company is in negotiations with dispensary operators, tobacco chain outlets, and major distributors in the US to begin distributing and marketing these two products. With these supply lines established, mCig, Inc. plans to integrate its m$ignature Series products of high end vaporizers and consumer accessories into an array of retail channels worldwide throughout 2015.

http://archive.aweber.com/mciglist1/LJHaL/h/m...coming.htm

Bots Inc. (BTZI) Stock Research Links

BTZI Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 2

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 4

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

Insightful Findings on gMG Treatments by UCB at AANEM 2024

Updated Category News Views 127

UCB Highlights Innovations in Generalized Myasthenia Gravis Treatments at AANEM 2024 UCB, a prominent global biopharmaceutical company, is gearing up to present its latest findings in the management of generalized myasthenia gravis (gMG) at the upcoming American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) meeting. The event, which will also feature...

Continue Reading
Lysander Funds Shares New Distributions Estimates for ETFs

Updated Category News Views 131

Lysander Funds Shares New Distributions Estimates Lysander Funds Limited recently made an announcement about the anticipated cash distributions for December 2024 for their exchange-traded funds (ETFs). The focus is on three notable ETFs: Lysander-Slater Preferred Share ActivETF, Lysander-Canso Corporate Treasury ActivETF, and Lysander-Canso Floating Rate ActivETF. Each of...

Continue Reading
Empowering Girls: Pace Center's Initiatives for Growth

Updated Category News Views 350

Introduction to the Capital Campaign Pace Center for Girls Hillsborough is excited to announce its capital campaign aimed at expanding its capacity and enhancing the support provided to girls in the community. Through dedicated efforts such as education, counseling, and training, this campaign signifies a crucial step towards bettering the future for girls in Hillsborough...

Continue Reading
Bank of America Sees Growth in Loans, Deposits Amid Profit Rise

Updated Category News Views 284

Bank of America Reports Increased Earnings and Efficiency Bank of America Corp (NASDAQ: BAC) has announced strong financial results for the second quarter, showcasing impressive growth in loans, deposits, and overall profitability. The bank reported a net income of $7.1 billion, a slight increase from $6.9 billion the previous year, along with an earnings per share (EPS)...

Continue Reading
Investigating Manitex International: A Closer Look at MNTX

Updated Category News Views 72

Examining Fair Treatment for Manitex International Shareholders Ademi LLP has launched an investigation into Manitex International, Inc. (NASDAQ: MNTX) due to concerns about possible breaches of fiduciary duty related to its recent transaction with Tadano. This investigation raises important questions about whether shareholders are being treated fairly in the financial...

Continue Reading